Brainstorm Cell Therapeutics Inc. Stock Forecast

Volatile ride for Brainstorm Cell Therapeutics Inc. stock price on Thursday moving between $0.451 and $0.590
(Updated on Apr 18, 2024)

BCLI Signals & Forecast

The Brainstorm Cell Therapeutics Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $0.556. On a fall, the stock will find some support from the long-term average at approximately $0.499. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, April 01, 2024, and so far it has fallen -30.49%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Brainstorm Cell Therapeutics Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Brainstorm Cell Therapeutics Inc. stock

Brainstorm Cell Therapeutics Inc. finds support from accumulated volume at $0.507 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.139 between high and low, or 30.76%. For the last week, the stock has had daily average volatility of 17.49%.

Our recommended stop-loss: $0.488 (-5.08%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 13 days ago.)

Trading Expectations (BCLI) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Brainstorm Cell Therapeutics Inc. to open at $0.519, and during the day (based on 14 day Average True Range), to move between $0.424 and $0.605, which gives a possible trading interval of +/-$0.0905 (+/-17.60%) up or down from last closing price. If Brainstorm Cell Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 35.20% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.507 (1.42%) than the resistance at $0.570 (10.83%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Brainstorm Cell Therapeutics Inc. stock A Buy?

Brainstorm Cell Therapeutics Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.768 Hold/Accumulate Downgraded

Predicted Opening Price for Brainstorm Cell Therapeutics Inc. of Friday, April 19, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.